08:43 AM EDT, 05/22/2025 (MT Newswires) -- LifeMD ( LFMD ) said Thursday it launched a $299 introductory offer for new self-pay patients prescribed Wegovy, as part of a collaboration with Novo Nordisk ( NVO ) .

The company said the offer includes a discounted $199 price for the medication and $100 for LifeMD's ( LFMD ) virtual weight loss program. The monthly price rises to $599 starting with the second month and the promotion applies to eligible patients who are prescribed Wegovy by June 30, the company added.

Shares of LifeMD ( LFMD ) were down more than 4% in recent Thursday premarket activity, while Novo Nordisk ( NVO ) stock fell 2%.